Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Smoking cessation

FDA considers lowering nicotine levels in cigarettes

Mandatory nicotine level regulation in cigarettes may help prevent 33 million young people from smoking, and stop 5 million adults from smoking, in one year, the United States Food and Drug Administration has said.

The United States government has said it will consider regulating to lower nicotine levels in cigarettes, in an effort to avoid millions of tobacco-related deaths across the country.

The Food and Drug Administration (FDA), the government agency responsible for evaluating the safety and efficacy of medicines in the United States, has announced an advance notice of proposed rulemaking (ANPRM) to explore a product standard, to lower nicotine in cigarettes to minimally or non-addictive levels, as part of its comprehensive plan on tobacco and nicotine regulation.

If the FDA is successful in making lower-nicotine levels in cigarettes mandatory in the country, 33 million young people could be prevented from smoking regularly, and around 5 million additional adult smokers could stop smoking within one year, the agency said.

FDA commissioner Scott Gottlieb said: “Given their combination of toxicity, addictiveness, prevalence and effect on non-users, it’s clear that to maximise the possible public health benefits of our regulation, we must focus our efforts on the death and disease caused by addiction to combustible cigarettes.”

The FDA’s plan stresses the importance of “harm reduction” — such as encouraging people to switch from traditional cigarettes to alternative to e-cigarettes.

Mr Gottlieb said the ANPRM provided “a wide-ranging review of the current scientific understanding about the role nicotine plays in creating or sustaining addiction to cigarettes”.

He said it will “seek comments on key areas, as well as additional research and data for public review, as we continue our consideration of developing a nicotine product standard”.

To help inform its findings and recommendations, the FDA said it would consider public input on such questions as what potential maximum nicotine level would be appropriate for the protection of public health, and whether standards for products should be implemented all at once, or gradually.

A spokesperson for UK campaigning health charity Action on Smoking and Health, said: “Currently, nicotine reduction is not under serious consideration in the UK; it was not part of the Department of Health’s Tobacco Control Plan published in July and would require legislation.”

 

 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20204579

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and British National Formulary for Children

    BNF and British National Formulary for Children

    Now available as a 1 year print subscription to both the BNF and British National Formulary for Children, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and British National Formulary for Children

    BNF and British National Formulary for Children

    Now available as a 2 year print subscription to both the BNF and British National Formulary for Children, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.